Cargando…
Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678756/ https://www.ncbi.nlm.nih.gov/pubmed/36425794 http://dx.doi.org/10.1016/j.jdin.2022.08.027 |
| _version_ | 1784834057524215808 |
|---|---|
| author | Migden, Michael Loquai, Carmen Robert, Caroline Baurain, Jean-François Squittieri, Nicholas Arntz, Ramon Dierlamm, Jörg Dréno, Brigitte |
| author_facet | Migden, Michael Loquai, Carmen Robert, Caroline Baurain, Jean-François Squittieri, Nicholas Arntz, Ramon Dierlamm, Jörg Dréno, Brigitte |
| author_sort | Migden, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9678756 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96787562022-11-23 Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks Migden, Michael Loquai, Carmen Robert, Caroline Baurain, Jean-François Squittieri, Nicholas Arntz, Ramon Dierlamm, Jörg Dréno, Brigitte JAAD Int Research Letter Elsevier 2022-10-18 /pmc/articles/PMC9678756/ /pubmed/36425794 http://dx.doi.org/10.1016/j.jdin.2022.08.027 Text en © 2022 Published by Elsevier Inc on behalf of the American Academy of Dermatology, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Research Letter Migden, Michael Loquai, Carmen Robert, Caroline Baurain, Jean-François Squittieri, Nicholas Arntz, Ramon Dierlamm, Jörg Dréno, Brigitte Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks |
| title | Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks |
| title_full | Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks |
| title_fullStr | Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks |
| title_full_unstemmed | Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks |
| title_short | Sonidegib improved quality of life in patients with advanced basal cell carcinoma: Results from the phase 2 Basal cell carcinoma outcomes with LDE225 treatment trial through 73 weeks |
| title_sort | sonidegib improved quality of life in patients with advanced basal cell carcinoma: results from the phase 2 basal cell carcinoma outcomes with lde225 treatment trial through 73 weeks |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678756/ https://www.ncbi.nlm.nih.gov/pubmed/36425794 http://dx.doi.org/10.1016/j.jdin.2022.08.027 |
| work_keys_str_mv | AT migdenmichael sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks AT loquaicarmen sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks AT robertcaroline sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks AT baurainjeanfrancois sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks AT squittierinicholas sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks AT arntzramon sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks AT dierlammjorg sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks AT drenobrigitte sonidegibimprovedqualityoflifeinpatientswithadvancedbasalcellcarcinomaresultsfromthephase2basalcellcarcinomaoutcomeswithlde225treatmenttrialthrough73weeks |